Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Dirk Evers, Kevin Shianna, Robin Slinger, Robert Bakewell

Premium

The New York Genome Center has appointed Dirk Evers and Kevin Shianna to its leadership team. Evers, who will serve as senior vice president of bioinformatics, joins NYGC from Illumina, where he led the company's computational biology efforts in the UK. Previously, he served as managing director of the International Graduate School in Bioinformatics and Genome Research at the Center for Biotechnology at Bielefeld University. He holds a PhD in natural sciences from Bielefeld University.

Shianna will serve as senior vice president of sequencing operations at the NYGC. He joins from Duke University, where he was an assistant professor in the School of Medicine, director of operations for the Center for Human Genome Variation, and founding director for the Genomic Analysis Facility. He holds a PhD from North Carolina State University.



Source BioScience
has made some changes to its board of directors (see related story, this issue). Non-executive director, Robin Slinger, who has been a board member since 2004, has stepped down, and Robert Bakewell has been appointed as a member of the board. Bakewell joined Source Bioscience in 2005 and has served as finance director in a non-board capacity since 2011.
The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.